INUS
Straddle Chart

Markets / Mutual funds / Other ETFs

Mutual fundsSIF

Nippon India Nifty Pharma ETF - Regular Plan - Growth

NAVs of 8 Nov 2026

Nippon India Mutual Fund · Index & ETFs fund · Regular plan · Growth

Other ETFsRegular · GrowthRisk: Very High
NAV · 6 Nov 2026
₹28.7243 ▲ 1.21%
Nippon India Mutual Fund
Fund size₹1,700 crJuly - September 2026
1-month range₹26.04 – 28.72
1 year+26.02%rank 3 of 176
3 years+23.86%a year
5 years+15.59%a year

What the fund does

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

BenchmarkNifty Pharma TRI
Launched2 Jul 2021
Fund houseNippon India Mutual Fund
Fund managersJitendra Tolani

NAV history

262729 2026-08-122026-08-252026-09-072026-09-212026-10-052026-10-162026-10-30

Returns

1 week
+3.01%avg 5.4%
1 month
+5.67%avg 4.2%
3 months
+5.24%avg -2.1%
6 months
+16.14%avg -0.7%
This year
+23.42%avg -4.5%
1 year
+26.02%avg -1.8% · #3/176
3 years (a year)
+23.86%avg 1.2% · #6/111
5 years (a year)
+15.59%avg -2.0% · #5/60

Bars: this plan; the thin mark is the Other ETFs average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+3.4
2025-6.8-7.4+6.7+1.6-0.2+2.4+3.6-3.7-1.4+3.1+3.7-1.2
2026-4.5+5.9-3.2+4.6+4.6+4.1+4.9+2.5-2.8+2.6+3.0

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Sept 2026

Stocks held2022 lines in all
Top 10 stocks78.2%of the fund
Short positions-0.1%sold through derivatives
Net equity99.8%long stocks and derivatives minus shorts

Where the money is

Equity 99.9%Cash & others 0.1%Short -0.1%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
99.9%

Changes since 31 Aug 2026

Share of fund30 Sept 202631 Aug 2026Change
Stocks held99.9%100.0%-0.01
Short positions-0.1%-0.0%-0.11
Cash & others0.1%0.1%+0.01
Top 10 stocks78.2%78.8%-0.66
Number of stocks20200
Bought more 2
  • Dr. Reddy's Laboratories Limited+0.67
  • Laurus Labs Limited+0.46
Cut back 3
  • Sun Pharmaceutical Industries Limited-1.25
  • Biocon Limited-0.28
  • Lupin Limited-0.25

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 20

HoldingSector / type% of fund
Sun Pharmaceutical Industries Limited
INE044A01036		Pharmaceuticals & Biotechnology19.50%
Divi's Laboratories Limited
INE361B01024		Pharmaceuticals & Biotechnology11.97%
Laurus Labs Limited
INE947Q01028		Pharmaceuticals & Biotechnology7.82%
Cipla Limited
INE059A01026		Pharmaceuticals & Biotechnology7.68%
Dr. Reddy's Laboratories Limited
INE089A01031		Pharmaceuticals & Biotechnology7.62%
Torrent Pharmaceuticals Limited
INE685A01028		Pharmaceuticals & Biotechnology7.16%
Lupin Limited
INE326A01037		Pharmaceuticals & Biotechnology5.00%
Aurobindo Pharma Limited
INE406A01037		Pharmaceuticals & Biotechnology4.69%
Glenmark Pharmaceuticals Limited
INE935A01035		Pharmaceuticals & Biotechnology3.56%
Alkem Laboratories Limited
INE540L01014		Pharmaceuticals & Biotechnology3.16%
Zydus Lifesciences Limited
INE010B01027		Pharmaceuticals & Biotechnology2.92%
Mankind Pharma Limited
INE634S01028		Pharmaceuticals & Biotechnology2.88%
IPCA Laboratories Limited
INE571A01038		Pharmaceuticals & Biotechnology2.71%
Biocon Limited
INE376G01013		Pharmaceuticals & Biotechnology2.62%
Gland Pharma Limited
INE068V01023		Pharmaceuticals & Biotechnology2.34%
Sai Life Sciences Limited
INE570L01029		Pharmaceuticals & Biotechnology2.14%
Wockhardt Limited
INE049B01025		Pharmaceuticals & Biotechnology1.77%
Ajanta Pharma Limited
INE031B01049		Pharmaceuticals & Biotechnology1.67%
Abbott India Limited
INE358A01014		Pharmaceuticals & Biotechnology1.43%
Piramal Pharma Limited
INE0DK501011		Pharmaceuticals & Biotechnology1.30%

Short positions 1

HoldingSector / type% of fund
Net Current Assets–-0.12%

Debt, money market and cash 1

HoldingSector / type% of fund
Triparty Repo–0.18%

From the fund house's monthly portfolio (mf.nipponindiaim.com), as on 30 Sept 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.

Risk

Volatility14.2%yearly, from daily NAVs
Worst fall-18.05%30 Sept 2021 → 28 Feb 2023
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 30 Jul 2021).

Fund details

Fund size (average AUM, July - September 2026)₹1,700 cr across all plans
Fund houseNippon India Mutual Fund
CategoryIndex & ETFs · Other ETFs
PlanRegular
OptionGrowth
Minimum investmentIn creation unit size of 75,000 units and in multiples thereafter However, in case of large investors, the execution value must be greater than Rs. 25 crores
Scheme code (AMFI)149008
ISININF204KC1089
NAV date6 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Top Other ETFs funds (regular plans)

Fund1 year3 years (a year)
ICICI PRUDENTIAL SILVER ETF+23.64%+36.23%
Nippon India Silver ETF+23.37%+35.89%
HDFC Silver ETF+23.10%+35.72%
Motilal Oswal Nasdaq Q50 ETF+31.47%+29.58%
Motilal Oswal Nasdaq 100 ETF+11.67%+26.04%
Nippon India Nifty Pharma ETF+26.02%+23.86%
Motilal Oswal BSE Healthcare ETF+16.43%+23.34%
ICICI Prudential Nifty Healthcare ETF+15.62%+21.94%

All Other ETFs funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of Nippon India Nifty Pharma ETF - Regular Plan - Growth today?

₹28.7243 as of 6 Nov 2026, from AMFI's official NAV data.

What are the returns of Nippon India Nifty Pharma ETF - Regular Plan - Growth?

1 year: 26.02%, 3 years: 23.86% a year, 5 years: 15.59% a year

How does Nippon India Nifty Pharma ETF rank in its category?

3 of 176 Other ETFs funds (regular plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.